Injecting human peripheral blood mononuclear cells into severe combined immunodeficient (SCID) mice results in long-term engraftment of human lymphocytes, of which > 98% are phenotypically mature, activated T cells. Here we have characterized the human T cells that populate such hu-PBL-SCID chimeras. We report that these human T cells do not mobilize Ca2+ after CD3 stimulation, i.e., their T cell receptor (TCR)-mediated signal transduction is deficient. Chimera-derived human T cells do not secrete lymphokines or undergo blastogenesis after CD3 stimulation, but proliferate in response to interleukin 2 (IL-2), defining the chimera derived human T cells as anergic. Anergy was seen in both the CD4+ and the CD8+ subpopulations. We established human T cell lines from chimeras. These T cells retained their anergic state for 1-2 mo in culture, after which they simultaneously regained the ability to mobilize Ca2+, secrete lymphokines, and to undergo blastogenesis following stimulation via the TCR. Once regaining proliferative responsiveness to CD3 stimulation, these CD4+ T cell lines displayed anti-SCID mouse reactivity and showed no specificity for recall antigens. All CD3-responsive CD4+ T cell clones obtained from such lines were SCID mouse specific, recognizing native major histocompatibility complex class II products on the murine cells. In contrast, chimera-derived human CD8+ cell lines and clones did not display detectable anti-mouse reactivity. The data show that the human T cell system in long term hu-PBL-SCID chimeras is nonfunctional due to both anergy and the limitation of the CD4+ repertoire to xenoreactive clones. The data suggest that long-term hu-PBL-SCID chimerism represents an atypical graft-versus-host reaction in which the human effector T cells become anergic in the murine environment.
Skip Nav Destination
Article navigation
Article|
November 01 1994
Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras.
M Tary-Lehmann,
M Tary-Lehmann
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.
Search for other works by this author on:
P V Lehmann,
P V Lehmann
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.
Search for other works by this author on:
D Schols,
D Schols
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.
Search for other works by this author on:
M G Roncarolo,
M G Roncarolo
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.
Search for other works by this author on:
A Saxon
A Saxon
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.
Search for other works by this author on:
M Tary-Lehmann
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.
P V Lehmann
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.
D Schols
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.
M G Roncarolo
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.
A Saxon
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1994) 180 (5): 1817–1827.
Citation
M Tary-Lehmann, P V Lehmann, D Schols, M G Roncarolo, A Saxon; Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras.. J Exp Med 1 November 1994; 180 (5): 1817–1827. doi: https://doi.org/10.1084/jem.180.5.1817
Download citation file:
Suggested Content
Email alerts
Advertisement